Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Janis L. Hammett"'
Autor:
Neville F. Ford, Neil R. Johnston, Neeraj Dhaun, David J. Webb, Maria Palmisano, David E. Newby, Janis L. Hammett, Fiona E. Strachan
Publikováno v:
British Journal of Clinical Pharmacology. 60:611-622
Aims A number of endothelin receptor antagonists (ERAs) are currently in clinical development as potential therapies in states characterized by vasoconstriction, such as systemic hypertension. We investigated the haemodynamic effects of locally and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13cff4f2b4d131b52fcbd09605c8170f
https://doi.org/10.1111/j.1365-2125.2005.02503.x
https://doi.org/10.1111/j.1365-2125.2005.02503.x
Publikováno v:
Current Therapeutic Research. 62:699-708
Background: Behavioral evidence from animal studies has suggested that ceronapril and other angiotensin-converting enzyme (ACE) inhibitors have some anxiolytic activity. Objectives: The objectives of this trial were to assess the effects of ceronapri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62806255e61752a5aefd27a251d90c2b
https://doi.org/10.1016/s0011-393x(01)80077-1
https://doi.org/10.1016/s0011-393x(01)80077-1
Publikováno v:
The Journal of Clinical Pharmacology. 38:1116-1121
A double-blind, placebo-controlled, parallel-group, ascending, multiple-dose study was completed in 45 healthy male volunteers to assess the maximum tolerated dose, pharmacokinetics, and pharmacodynamics of BMS-187745, a squalene synthase inhibitor,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85b6fa74b7883a1b3f3e0ed3ef3304f9
https://doi.org/10.1177/009127009803801205
https://doi.org/10.1177/009127009803801205
Publikováno v:
Pharmaceutical Research. 15:1782-1786
Purpose. To estimate and compare the oral bioavailability of a drug (BMS-187745) administered as single doses of oral solution of either the parent drug or its prodrug (BMS-188494). Methods. A single-dose, two-period, three-treatment, control-balance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93719e5dbbc3133942b647f7e07b238d
https://doi.org/10.1023/a:1011977116543
https://doi.org/10.1023/a:1011977116543
Autor:
Ralph H. Raymond, Janis L. Hammett, Domenic A. Sica, Peter H. Slugg, Todd W.B. Gehr, Neville F. Ford
Publikováno v:
European Journal of Clinical Pharmacology. 53:117-121
Objective: The single-dose and steady-state pharmacokinetics of the HMG CoA reductase inhibitor pravastatin and its two metabolites, SQ 31 906 and SQ 31 945, were evaluated in 12 hemodialysis patients. A single 20-mg i.v. dose was employed, followed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04fd4ea218684d977bb77c5e716b614f
https://doi.org/10.1007/s002280050348
https://doi.org/10.1007/s002280050348
Autor:
Ralph H. Raymond, Neville F. Ford, Hester Tr, Janis L. Hammett, Turnbull D, Gale Pj, Frankos Vh, Cohen Mb
Publikováno v:
Plastic and Reconstructive Surgery. 100:1291-1298
The objective of this matched case-control study was to determine whether women with Même or Replicon polyurethane-covered silicone breast implants are exposed to clinically significant levels of free 2,4-TDA from biodegradation of the polyurethane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a7cb8d488a44519bae9662b44dd4c25
https://doi.org/10.1097/00006534-199710000-00035
https://doi.org/10.1097/00006534-199710000-00035
Autor:
Howard D. Uderman, Janis L. Hammett, Kathleen M. Langenbacher, Maria R. Marino, Peter Nichola
Publikováno v:
Journal of Clinical Psychopharmacology. 17:27-33
The effect of nefazodone on the pharmacokinetics of a single dose of phenytoin was evaluated in 18 healthy male subjects. The subjects received a single oral dose of phenytoin, 300 mg, on day 1 of the study and the pharmacokinetic profile of the drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16b398ecedd6bc2fb3f2409a4bc39064
https://doi.org/10.1097/00004714-199702000-00006
https://doi.org/10.1097/00004714-199702000-00006
Autor:
Neeraj, Dhaun, Fiona E, Strachan, David E, Newby, Neil R, Johnston, Neville F, Ford, Janis L, Hammett, Maria, Palmisano, David J, Webb
Publikováno v:
British journal of clinical pharmacology. 60(6)
A number of endothelin receptor antagonists (ERAs) are currently in clinical development as potential therapies in states characterized by vasoconstriction, such as systemic hypertension. We investigated the haemodynamic effects of locally and system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::874e2e7ed10dce8323132989049c07f6
https://pubmed.ncbi.nlm.nih.gov/16305585
https://pubmed.ncbi.nlm.nih.gov/16305585
Autor:
Wei‐chi Liao, Ole Vesterqvist, James A. Manning, H. Wayne Hutman, Kathy D. Davis, Alan Meier, Janis L. Hammett, Irene Ferreira
Publikováno v:
The American journal of geriatric cardiology. 10(1)
Omapatrilat is the most clinically advanced member of a new class of cardiovascular drugs, vasopeptidase inhibitors. Omapatrilat is a single molecule that simultaneously inhibits neutral endopeptidase and angiotensin-converting enzyme, thus preservin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e82d78901838c4bb084427cefbbed89
https://pubmed.ncbi.nlm.nih.gov/11413936
https://pubmed.ncbi.nlm.nih.gov/11413936
Autor:
Ralph H. Raymond, Neville F. Ford, Janis L. Hammett, James Manning, Donald R. Van Harken, Kenneth C. Lasseter
Publikováno v:
Journal of clinical pharmacology. 35(2)
The single-dose and steady-state pharmacokinetics of the angiotensin-converting enzyme (ACE) inhibitor fosinopril and its active diacid, fosinoprilat, were evaluated in 6 healthy volunteers and 12 patients with alcoholic cirrhosis. Fosinopril was adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e37eae873a7d0b753511fcc51f6d68
https://pubmed.ncbi.nlm.nih.gov/7751424
https://pubmed.ncbi.nlm.nih.gov/7751424